Bundamedik Tbk PT (BMHS) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.083x

Based on the latest financial reports, Bundamedik Tbk PT (BMHS) has a cash flow conversion efficiency ratio of 0.083x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp199.64 Billion ≈ $11.70 Million USD) by net assets (Rp2.39 Trillion ≈ $140.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bundamedik Tbk PT balance sheet independence to measure how much of total assets are equity-financed.

Bundamedik Tbk PT - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Bundamedik Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Bundamedik Tbk PT (BMHS) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Bundamedik Tbk PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bundamedik Tbk PT ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Galleon Gold Corp
V:GGO
-0.008x
LBG MEDIA PLC LS -001
F:S83
0.059x
China Silver Group Limited
F:2CS
0.013x
Yirendai Ltd
NYSE:YRD
-0.001x
AKA Brands Holding Corp
NYSE:AKA
-0.041x
Technical Olympic S.A
AT:OLYMP
-0.002x
PT Surya Pertiwi Tbk
JK:SPTO
0.021x
Unique Engineering and Construction Public Company Limited
BK:UNIQ
0.005x

Annual Cash Flow Conversion Efficiency for Bundamedik Tbk PT (2018–2025)

The table below shows the annual cash flow conversion efficiency of Bundamedik Tbk PT from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Bundamedik Tbk PT (BMHS) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Rp2.39 Trillion
≈ $140.31 Million
Rp250.62 Billion
≈ $14.69 Million
0.105x +561.56%
2024-12-31 Rp2.15 Trillion
≈ $125.85 Million
Rp33.98 Billion
≈ $1.99 Million
0.016x -44.64%
2023-12-31 Rp1.80 Trillion
≈ $105.47 Million
Rp51.44 Billion
≈ $3.01 Million
0.029x -78.24%
2022-12-31 Rp1.81 Trillion
≈ $105.96 Million
Rp237.47 Billion
≈ $13.91 Million
0.131x -36.61%
2021-12-31 Rp1.69 Trillion
≈ $98.84 Million
Rp349.44 Billion
≈ $20.48 Million
0.207x +14.24%
2020-12-31 Rp1.05 Trillion
≈ $61.51 Million
Rp190.36 Billion
≈ $11.15 Million
0.181x +34.54%
2019-12-31 Rp665.59 Billion
≈ $39.00 Million
Rp89.72 Billion
≈ $5.26 Million
0.135x +63.82%
2018-12-31 Rp532.23 Billion
≈ $31.19 Million
Rp43.79 Billion
≈ $2.57 Million
0.082x --

About Bundamedik Tbk PT

JK:BMHS Indonesia Medical Care Facilities
Market Cap
$95.78 Million
Rp1.63 Trillion IDR
Market Cap Rank
#19270 Global
#329 in Indonesia
Share Price
Rp190.00
Change (1 day)
+2.70%
52-Week Range
Rp147.00 - Rp226.00
All Time High
Rp1133.21
About

PT Bundamedik Tbk provides health care services in Indonesia. It also engages private hospital and healthcare support service activities; provision of ambulance services; private health education; consultant for reproductive technology services management; management consultant of physiotherapy service; and hotel, and dental clinic services management consulting businesses. It also provides ferti… Read more